BioMensio
Tampere
About BioMensio
Biomensio is revolutionizing analytics through its Diagnostics-as-a-Service Platform. The platform consists of a fully digital handheld reader, multianalyte fluid cartridges, and a cloud-based analytics service powered by professional services team. DXaaS provides an easier access for OEM partners to develop bio analysis products and services. Their initial application areas of interest are point-of-need applications including the detection of drug abuse in saliva, as well as food and milk safety.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.7M
- Last round: Grant (Jan 2019)
- Website: biomensio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/biomensio-136318 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.